Skip Navigation

JNCI Journal of the National Cancer Institute 1998 90(9):684-690; doi:10.1093/jnci/90.9.684
© 1998 by Oxford University Press
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Yahata, N.
Right arrow Articles by Toyama, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yahata, N.
Right arrow Articles by Toyama, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal Of The National Cancer Institute, Vol 90, 684-690, Copyright © 1998 by Oxford University Press


ARTICLES

Telomerase activity in lung cancer cells obtained from bronchial washings

N Yahata, K Ohyashiki, JH Ohyashiki, H Iwama, S Hayashi, K Ando, T Hirano, T Tsuchida, H Kato, JW Shay and K Toyama
First Department of Internal Medicine, Tokyo Medical College, Japan.

BACKGROUND: Telomerase, a ribonucleoprotein enzyme that functions in the maintenance of telomeres (specialized structures at the ends of chromosomes), has been reported to be a novel diagnostic marker for malignant diseases. We sought to determine whether measurement of telomerase activity in bronchial washings is of value in the diagnosis of lung cancer. METHODS: Extracts of cells in bronchial washings were analyzed for telomerase activity by use of a telomeric repeat amplification protocol (TRAP) assay. Telomerase activity inside cells was evaluated by use of an in situ TRAP assay. The results of both TRAP assays were compared with those obtained from cytologic examination, which employed standard Papanicolaou staining. RESULTS: When results from the two TRAP assays were combined, telomerase activity was detected in bronchial washings from 18 (82%; 95% confidence interval [CI] = 60%-95%) of 22 patients with lung cancer. In contrast, cancer cells were detected by cytologic examination in the bronchial washings of nine (41%; 95% CI = 21%-64%) of the same 22 patients, a statistically significant difference (two-sided P = .0061). In patients with lung cancer, telomerase-positive cells could be detected in bronchial washings irrespective of tumor location--11 of 14 (79%; 95% CI = 49%-95%) peripheral cancerous lesions and seven of eight (88%; 95% CI = 47%-100%) central cancerous lesions were detected by use of TRAP assays (for comparison, two-sided P = .5349). CONCLUSIONS: A high percentage of patients with lung cancers had detectable telomerase activity in bronchial washings. Thus, the use of a cell extract-based or an in situ TRAP assay in addition to cytologic examination may make the diagnosis of lung cancer more reliable.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JAMAHome page
M. A. Sanchini, R. Gunelli, O. Nanni, S. Bravaccini, C. Fabbri, A. Sermasi, E. Bercovich, A. Ravaioli, D. Amadori, and D. Calistri
Relevance of Urine Telomerase in the Diagnosis of Bladder Cancer
JAMA, October 26, 2005; 294(16): 2052 - 2056.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
E. Dikmen, M. Kara, G. Dikmen, H. Cakmak, and P. Dogan
Detection of telomerase activity in bronchial lavage as an adjunct to cytological diagnosis in lung cancer
Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 194 - 199.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. L. Hess and W. E. Highsmith Jr
Telomerase Detection in Body Fluids
Clin. Chem., January 1, 2002; 48(1): 18 - 24.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Ohno, Y. Horio, Y. Sekido, Y. Hasegawa, M. Takahashi, J.-i. Nishizawa, H. Saito, F. Ishikawa, and K. Shimokata
Telomerase activation and p53 mutations in urethane-induced A/J mouse lung tumor development
Carcinogenesis, May 1, 2001; 22(5): 751 - 756.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. R. Hirsch, W. A. Franklin, A. F. Gazdar, and P. A. Bunn Jr.
Early Detection of Lung Cancer: Clinical Perspectives of Recent Advances in Biology and Radiology
Clin. Cancer Res., January 1, 2001; 7(1): 5 - 22.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
M. Arinaga, S. Shimizu, K. Gotoh, N. Haruki, T. Takahashi, T. Takahashi, and T. Mitsudomi
Expression of human telomerase subunit genes in primary lung cancer and its clinical significance
Ann. Thorac. Surg., August 1, 2000; 70(2): 401 - 405.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Meyerson
Role of Telomerase in Normal and Cancer Cells
J. Clin. Oncol., July 1, 2000; 18(13): 2626 - 2634.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
W. N. ROM, J. G. HAY, T. C. LEE, Y. JIANG, and K.-M. TCHOU-WONG
Molecular and Genetic Aspects of Lung Cancer
Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1355 - 1367.
[Full Text]


Home page
Clin. Cancer Res.Home page
M. Saji, S. Xydas, W. H. Westra, C.-K. Liang, D. P. Clark, R. Udelsman, C. B. Umbricht, S. Sukumar, and M. A. Zeiger
Human Telomerase Reverse Transcriptase (hTERT) Gene Expression in Thyroid Neoplasms
Clin. Cancer Res., June 1, 1999; 5(6): 1483 - 1489.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.